Southwest Kidney Dialysis - Tempe (DVA) is a medicare approved dialysis facility center in Tempe, Arizona and it has 24 dialysis stations. It is located in Maricopa county at 2149 E Warner Rd Ste 109 & Ste 110, Tempe, AZ, 85284. You can reach out to the office of Southwest Kidney Dialysis - Tempe (DVA) at (480) 730-3531. This dialysis clinic is managed and/or owned by Davita. Southwest Kidney Dialysis - Tempe (DVA) has the following ownership type - Profit. It was first certified by medicare in August, 2005. The medicare id for this facility is 032609 and it accepts patients under medicare ESRD program.
| Name | Southwest Kidney Dialysis - Tempe (DVA) |
|---|---|
| Location | 2149 E Warner Rd Ste 109 & Ste 110, Tempe, Arizona |
| No. of Dialysis Stations | 24 |
| Medicare ID | 032609 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 2149 E Warner Rd Ste 109 & Ste 110, Tempe, Arizona, 85284 | |
| (480) 730-3531 | |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
| NPI Number | 1134178007 |
| Doing Business As | Southwest Kidney Dialysis, Llc |
| Address | 2149 E Warner Rd Tempe, Arizona, 85284 |
| Phone Number | (480) 610-6170 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
| NPI Number | 1578746277 |
| Organization Name | Tempe Dialysis Center |
| Doing Business As | Southwest Kidney Davita Dialysis Partners Llc |
| Address | 2149 E Warner Rd Tempe, Arizona, 85284 |
| Phone Number | (480) 730-3531 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 74% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 16% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 10% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 66% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 29% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 14% |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 68% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 19% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 13% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 71% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 28% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 1% | 12% |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 82% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 18% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 76% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 1% | 12% |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 107 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 21 |
| Medicare patients who had average hemoglobin (hgb) greater than 12 g/dL | 1 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 148 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1146 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
| Adult patients getting regular peritoneal dialysis at the center | 157 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 1228 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 96 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Southwest Kidney Dialysis - Tempe (DVA) with elevated calcium levels.
| Patients with hypercalcemia | 319 |
| Hypercalcemia patient months | 2595 |
| Patients with Serumphosphor | 331 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 34 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 19 |
| Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 138 |
| Patient months included in arterial venous fistula and catheter summaries | 888 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 79 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 228 |
| Hospitalization Rate in facility | 174.6 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 256.9 |
| Hospitalization Rate: Lower Confidence Limit | 125.8 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Southwest Kidney Dialysis - Tempe (DVA) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 24.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 30.4 |
| Readmission Rate: Lower Confidence Limit | 18.8 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Southwest Kidney Dialysis - Tempe (DVA) get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .73 (As Expected) |
| SIR: Upper Confidence Limit | 1.52 |
| SIR: Lower Confidence Limit | .3 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Southwest Kidney Dialysis - Tempe (DVA)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 192 |
| Transfusion Rate in facility | 28 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 55.2 |
| Transfusion Rate: Lower Confidence Limit | 15.4 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Southwest Kidney Dialysis - Tempe (DVA) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 1343 |
| Mortality Rate in facility | 19.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 22.7 |
| Mortality Rate: Lower Confidence Limit | 16.3 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago
Southwest Kidney Dialysis - Tempe (DVA) Location: 2149 E Warner Rd Ste 109 & Ste 110, Tempe, Arizona, 85284 Phone: (480) 730-3531 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.
The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
› Verified 2 days ago